MICHAEL COHEN: Open Payments
NPI 1316057821 · POOLER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,298 in 135 payments from 23 companies in 2025. Trend: 2023 $2,279 · 2024 $2,278 · 2025 $2,298
Food & beverage: $2,298
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 20 | $321 |
| Novo Nordisk Inc | 21 | $281 |
| Lilly USA, LLC | 12 | $202 |
| ABBVIE INC. | 12 | $202 |
| AstraZeneca Pharmaceuticals LP | 7 | $162 |
| Astellas Pharma US Inc | 6 | $118 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $95 |
| Dexcom, Inc. | 6 | $92 |
| IBSA Pharma Inc. | 2 | $80 |
| GlaxoSmithKline, LLC. | 5 | $77 |
Products named: ELIQUIS, QULIPTA, NURTEC ODT, Veozah, MOUNJARO, FARXIGA, Ozempic, XIFAXAN.
Industry payments across GA — which companies pay providers there.
